Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.5176
Delayed Data
As of 11:22am ET
 -0.0062 / -1.18%
Today’s Change
0.32
Today|||52-Week Range
4.66
-83.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues772.0K809.0K1.5M1.7M
 
 
 
 
 
Depreciation And Amortization14.0K12.0K11.0K56.0K
 
 
 
 
 
 
Operating ExpensesGross Income758.0K797.0K1.4M--
 
 
 
 
General Expenses44.6M56.3M102.6M128.0M
 
 
 
 
 
Research And Development28.9M43.9M85.6M103.1M
 
 
 
 
 
Total Operating Expenses44.6M56.3M102.6M128.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.8M-55.5M-101.1M-126.3M
 
 
 
 
 
Extraordinary Credit1.1M1.2M449.0K15.7M
 
 
 
 
 
Extraordinary Charge-9.1M-10.6M-34.0M0.00
 
 
 
 
Interest Expense On Debt15.5M873.0K996.0K4.2M
 
 
 
 
 
Other Expenses0.00-1.0K23.0K20.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-67.3M-65.8M-135.6M-114.7M
 
 
 
 
 
Net Income-67.3M-65.8M-135.6M-114.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.8M32.9M59.2M77.7M
 
 
 
 
 
Shares To Calculate EPS Diluted11.8M32.9M59.2M77.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.72-$2.00-$2.29-$1.48
 
 
 
 
 
EPS Diluted-$5.72-$2.00-$2.29-$1.48